Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
PureTech Health, a leading name in the pharmaceutical preparation manufacturing industry, is headquartered in the United States. Founded in 2008, the company has established itself as a pioneer in developing innovative therapeutics and drug delivery systems, focusing on areas such as immunology, neurology, and oncology.
With a commitment to advancing healthcare, PureTech Health is known for its unique approach to drug development, leveraging its proprietary platforms to create differentiated products that address unmet medical needs. The company has achieved significant milestones, including strategic partnerships and successful clinical trials, solidifying its position in the competitive pharmaceutical landscape.
Recognised for its cutting-edge research and development, PureTech Health continues to push the boundaries of science, aiming to improve patient outcomes and transform the future of medicine.
+1 vs industry average
Puretech Health’s score of 43 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Scope 3 accounts for ••• of total emissions.
PureTech Health, a Pharmaceutical Preparation Manufacturing company headquartered in the US, has reported its carbon emissions for several years. In 2024, the company's total reported emissions were approximately 139,300 kg CO2e. This figure comprises Scope 1 emissions of about 3,200 kg CO2e and Scope 2 emissions of approximately 60,500 kg CO2e (market-based). Scope 3 emissions for 2024 amounted to roughly 75,600 kg CO2e.
For 2023, PureTech Health reported total emissions of approximately 166,700 kg CO2e, with Scope 1 at around 3,900 kg CO2e, Scope 2 at approximately 54,900 kg CO2e (market-based), and Scope 3 at about 108,000 kg CO2e.
Looking back, in 2022, total emissions were approximately 665,000 kg CO2e, including Scope 1 of about 10,600 kg CO2e and Scope 2 of around 402,600 kg CO2e (market-based). Scope 3 emissions in 2022 were approximately 251,900 kg CO2e.
In 2021, total emissions were reported as approximately 464,200 kg CO2e, with Scope 1 at about 17,700 kg CO2e, Scope 2 at approximately 116,900 kg CO2e (market-based), and Scope 3 at roughly 329,600 kg CO2e.
The year 2020 saw total emissions of approximately 379,500 kg CO2e, including Scope 1 emissions of about 25,900 kg CO2e and Scope 2 emissions of approximately 146,800 kg CO2e (market-based). Scope 3 emissions for 2020 were around 232,700 kg CO2e.
For 2019, total emissions were approximately 760,600 kg CO2e, with Scope 1 at about 24,300 kg CO2e and Scope 2 at roughly 103,900 kg CO2e. Scope 3 emissions for 2019 were a significant portion, totalling approximately 656,700 kg CO2e.
In 2018, the company reported total emissions of about 1,378,800 kg CO2e, consisting of Scope 1 emissions of approximately 33,300 kg CO2e and Scope 2 emissions of around 178,900 kg CO2e (market-based). Scope 3 emissions for 2018 were approximately 1,199,900 kg CO2e.
PureTech Health has demonstrated a commitment to climate action by signing The Climate Pledge on 21 April 2026. This initiative signifies a commitment to net-zero carbon emissions by 2040. The company's reporting indicates that data may be cascaded from PureTech Health plc. Notably, a data point for "scope_3/purchased_goods_and_services" is listed as missing for multiple reporting years.
No climate goals have been disclosed for Puretech Health yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about Puretech Health’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more